Crystal's MCW Coder Hub🧠 CPT Code 64642 — Chemodenervation of One Extremity; 1-4 Muscle(s)
Quick Reference
📋 Clinical Description
CPT 64642 describes the percutaneous injection of a chemical neurolytic agent — most commonly botulinum toxin A or B — into one to four muscles of a single extremity to treat spasticity or focal limb dystonia. The injected agent acts at the neuromuscular junction to temporarily block acetylcholine release, producing localized, reversible muscle relaxation in the targeted motor units. The clinical effect typically emerges within 3-7 days of injection and lasts 3-6 months depending on the toxin preparation, dosage, and the underlying condition driving the spasticity.
This code captures the first extremity injected in a single encounter and encompasses 1 to 4 muscles within that extremity. It is the primary parent code to which all chemodenervation add-on codes (64643 for additional extremities with 1-4 muscles, 64645 for additional extremities with 5 or more muscles) are anchored. The number of muscles injected — not the number of injection sites or units of toxin — determines whether 64642 (1-4 muscles) or 64644 (5 or more muscles) is the appropriate primary code for the first extremity.
This procedure may be performed in the following clinical contexts:
- Post-stroke upper or lower limb spasticity — the most common indication; targets muscles such as the biceps brachii, wrist/finger flexors, or gastrocnemius
- Cerebral palsy — focal or multifocal extremity spasticity in pediatric and adult patients
- Multiple sclerosis — refractory limb spasticity not controlled by oral baclofen or tizanidine
- Traumatic brain injury (TBI) / spinal cord injury (SCI) — upper and lower motor neuron dysfunction driving limb posturing
- Focal limb dystonia — task-specific or action-induced dystonia affecting a discrete muscle group
- Contracture prophylaxis — prevention of fixed joint contractures in high-tone extremities
🔬 Clinical & Anatomical Considerations
| Extremity | Common Target Muscles (1-4 Muscle Scenario) | Primary Indication |
|---|---|---|
| Upper Limb — Arm | Biceps brachii, brachialis (elbow flexion posture) | Post-stroke flexor synergy pattern |
| Upper Limb — Forearm/Hand | Flexor carpi radialis, flexor carpi ulnaris, flexor digitorum superficialis | Wrist/finger flexion posturing, clenched fist |
| Lower Limb — Leg | Gastrocnemius, soleus (equinus foot) | Spastic equinus/toe-walking gait |
| Lower Limb — Thigh | Rectus femoris, hamstrings | Stiff-knee gait, scissoring gait pattern |
Clinical Pearl — Muscle Count Rules
The number of muscles injected, not the number of injection sites, determines code selection. A single muscle (eg, gastrocnemius) injected at multiple sites = 1 muscle. The medial and lateral heads of the gastrocnemius are typically considered 1 functional muscle unit for coding purposes unless the operative documentation specifically identifies them as separate muscles. When in doubt, query the injecting physician for a clear muscle count. Crossing from 4 to 5 muscles in a single extremity changes the primary code from 64642 to 64644 — this distinction carries meaningful reimbursement implications and must be supported by documentation.
✅ Procedure Includes
- Pre-injection assessment of muscle tone, spasticity grade (modified Ashworth), and target muscle identification
- Needle placement into 1-4 muscles of the single target extremity, percutaneous
- Injection of botulinum toxin or other chemical neurolytic agent into the targeted muscle(s)
- Needle repositioning within the same muscle for multi-site injection within one muscle (not counted as additional muscles)
- Basic post-injection monitoring and patient instructions
- Documentation of: specific muscle(s) injected, laterality, injection technique, agent used, dosage, and clinical rationale
✅ Separately Reportable (Not Included)
- 95874 — Needle EMG for guidance in conjunction with chemodenervation (list separately in addition to 64642) — required when EMG is used to confirm needle placement in the target muscle
- 76942 — Ultrasonic guidance for needle placement, imaging supervision and interpretation — separately reportable when ultrasound is used for real-time injection guidance; requires permanent image documentation
- J0585 — OnabotulinumtoxinA (Botox), per unit — bill separately for the actual drug administered; units reflect total toxin units injected, NOT procedure units
- J0586 — AbobotulinumtoxinA (Dysport), per 5 units
- J0587 — RimabotulinumtoxinB (Myobloc), per 100 units
- J0588 — IncobotulinumtoxinA (Xeomin), per unit
Drug Billing Note
The botulinum toxin drug itself (J-code) is always billed separately from the procedure code (64642). Never attempt to include the drug cost in the procedure charge. The J-code units must correspond to the actual number of toxin units administered, as documented in the procedure note. Discrepancies between documented dose and billed J-code units are a known audit target.
❌ Excludes / Do Not Report Together
| Code | Description | Relationship to 64642 |
|---|---|---|
| 64644 | Chemodenervation of one extremity; 5 or more muscle(s) | Mutually exclusive with 64642 for the same extremity — use 64644 when 5 or more muscles are injected in the first extremity; do NOT report both for the same limb |
| 64615 | Chemodenervation of muscle(s); muscle(s) innervated by facial, trigeminal, cervical spinal, and accessory nerves | CPT parenthetical guidelines explicitly prohibit reporting 64615 in conjunction with 64642 |
| 64616 | Chemodenervation of neck muscle(s), excluding laryngeal muscles | Different anatomic region (cervical); separately reportable when neck and extremity chemodenervation are performed in the same session with documentation supporting distinct sites |
| 64646 | Chemodenervation of trunk muscle(s); 1-5 muscle(s) | Trunk muscles are a separate anatomic domain; separately reportable when trunk and extremity injections both occur in the same session |
Bundling Alert
Do NOT report 64642 and 64644 for the same extremity in the same session. When 5 or more muscles of the same extremity are injected, 64644 is the correct primary code — it fully subsumes the work of injecting that limb regardless of how many muscles were treated. Splitting the muscles across both codes for the same limb constitutes unbundling and will trigger NCCI edits.
🌳 Code Tree — Destruction by Neurolytic Agent (Extremity Chemodenervation)
CPT 64600-64681 Surgery: Destruction by Neurolytic Agent
│
├── 64600-64610 Cranial Nerve Destruction
│ ├── 64600 Destruction, trigeminal nerve (gasserian ganglion)
│ └── 64610 Trigeminal nerve; secondary branches
│
├── 64612-64617 Chemodenervation — Head, Neck, Larynx
│ ├── 64612 Chemodenervation; muscle(s) innervated by facial nerve, unilateral
│ ├── 64615 Chemodenervation; facial, trigeminal, cervical spinal, and accessory nerves
│ ├── 64616 Chemodenervation; neck muscle(s), excluding laryngeal muscles
│ └── 64617 Chemodenervation; larynx, for spasmodic dysphonia
│
├── 64624-64625 Eccrine Glands / Spinal Cord
│ ├── 64624 Chemodenervation of eccrine glands; both axillae
│ └── 64625 Chemodenervation, targeted; spinal cord (dorsal or ventral horn)
│
├── 64640 Destruction of other peripheral nerve or branch
│
├── ▶▶ 64642 ◀◀ Chemodenervation, 1 extremity; 1-4 muscle(s) ← YOU ARE HERE
├── +64643 Chemodenervation, each additional extremity; 1-4 muscle(s) [Add-on to 64642 or 64644]
├── 64644 Chemodenervation, 1 extremity; 5 or more muscle(s)
├── +64645 Chemodenervation, each additional extremity; 5 or more muscle(s) [Add-on to 64644 or 64642]
│
├── 64646-64647 Chemodenervation — Trunk
│ ├── 64646 Chemodenervation of trunk muscle(s); 1-5 muscle(s)
│ └── +64647 Chemodenervation of trunk muscle(s); each additional trunk muscle [Add-on]
│
└── 64650-64653 Eccrine Glands (other areas)
💰 RVU & Reimbursement Profile
| Component | Value |
|---|---|
| Work RVU (wRVU) | 1.61 |
| Practice Expense RVU | 2.89 |
| Malpractice RVU | 0.39 |
| Total RVU | 4.89 |
| Global Period | 000 (0 days) |
| Bilateral Indicator | 0 — not subject to bilateral reduction; each additional extremity uses 64643 or 64645 |
| Assistant Surgeon | ❌ Not payable |
| PC/TC Split | ❌ No — procedure code only (Indicator 0) |
| Modifier -51 Exempt | No |
Understanding the Billing Structure
Unlike most bilateral procedures where modifier -50 triggers a payment adjustment, 64642 does not use modifier -50. Instead, the AMA CPT parenthetical structure requires that each additional extremity be captured with add-on code 64643 (1-4 muscles) or 64645 (5 or more muscles). These add-on codes do NOT require modifier -51 and are paid in addition to the primary code. A session treating all four extremities would generate: 64642 (first limb) + 64643 × 3 (three additional limbs).
🏷️ Modifier Reference
| Modifier | Name | When to Apply |
|---|---|---|
| -RT | Right Side | Identifies which extremity was injected; not always required for payment but strongly recommended for documentation clarity and audit defense |
| -LT | Left Side | Identifies left-sided extremity treatment |
| -25 | Significant, Separately Identifiable E/M | Applied to the E/M code — not 64642 — when the same-day office visit involves evaluation beyond the standard pre-injection assessment; requires distinct documentation |
| -59 | Distinct Procedural Service | When 64642 is reported alongside another procedure that payer edits may bundle; documents distinct anatomic site or independent service |
| -52 | Reduced Services | Injection partially completed |
| -53 | Discontinued Procedure | Stopped due to patient safety; document reason thoroughly |
🩺 Common ICD-10-CM Pairings
Post-Stroke / Acquired Spasticity
| ICD-10 Code | Description | HCC? | HCC Category (v28) | Clinical Notes |
|---|---|---|---|---|
| G81.10 | Spastic hemiplegia affecting unspecified side | ✅ Yes | HCC Motor/Cognitive | Use when documentation does not specify dominant vs. non-dominant side; query provider for specificity |
| G81.11 | Spastic hemiplegia affecting right dominant side | ✅ Yes | HCC Motor/Cognitive | Right-dominant hemiplegia; most specific when laterality and dominance are documented |
| G81.12 | Spastic hemiplegia affecting left dominant side | ✅ Yes | HCC Motor/Cognitive | Left-dominant hemiplegia |
| I69.351 | Hemiplegia and hemiparesis following cerebral infarction, right dominant side | ✅ Yes | Stroke Sequelae HCC | Preferred when spasticity is documented as a direct sequela of a prior stroke; establishes etiology |
| I69.352 | Hemiplegia and hemiparesis following cerebral infarction, left dominant side | ✅ Yes | Stroke Sequelae HCC | Left-sided post-stroke hemiplegia sequela |
Cerebral Palsy
| ICD-10 Code | Description | HCC? | Clinical Notes |
|---|---|---|---|
| G80.0 | Spastic quadriplegic cerebral palsy | ✅ Yes | All four extremities involved; supports multi-extremity chemodenervation sessions with 64643 add-ons |
| G80.1 | Spastic diplegic cerebral palsy | ✅ Yes | Primarily lower limbs; bilateral lower extremity injections common |
| G80.2 | Spastic hemiplegic cerebral palsy | ✅ Yes | One-sided involvement; typically one upper and one lower extremity |
Systemic Neurological Conditions
| ICD-10 Code | Description | HCC? | Clinical Notes |
|---|---|---|---|
| G82.20 | Paraplegia, unspecified | ✅ Yes | Spinal cord injury etiology; lower extremities bilateral; add-on 64643 for second limb |
| G82.50 | Quadriplegia, unspecified | ✅ Yes | All four limbs; supports up to 64642 + 64643 × 3 in a single session |
| G35.- | Multiple sclerosis | ✅ Yes | Episodic or progressive spasticity; document exacerbation or progressive course when applicable |
Focal Dystonia
| ICD-10 Code | Description | HCC? | Clinical Notes |
|---|---|---|---|
| G24.1 | Genetic torsion dystonia | ❌ No | Hereditary etiology; document family history and genetic workup if available |
| G24.2 | Idiopathic non-familial dystonia | ❌ No | No identifiable genetic cause; most common focal dystonia category for extremity injections |
Other / Symptom Codes
| ICD-10 Code | Description | HCC? | Clinical Notes |
|---|---|---|---|
| R25.2 | Cramp and spasm | ❌ No | Lower specificity; use only when a definitive spasticity diagnosis has not yet been established; query for a more specific etiology when possible |
| M62.411 | Contracture of muscle, right shoulder | ❌ No | When chemodenervation is directed at preventing or treating muscle contracture; use the most specific anatomic location code available |
CMS LCD — Spasticity Coverage
Per CMS Billing and Coding Article A57185, 64642 and 64643 are covered for upper and lower limb spasticity under Group 19 of the covered diagnoses. The applicable ICD-10-CM codes from Group 19 span M62.411-M62.838 (muscle spasm) as well as the hemiplegia, paraplegia, quadriplegia, and cerebral palsy categories. Always verify current CMS LCD/LCA coverage for the applicable MAC jurisdiction prior to submission, as covered diagnosis lists are updated periodically.
🏥 MS-DRG Considerations (Inpatient)
Inpatient Coding Reminder
CPT 64642 is not used in the inpatient facility setting — ICD-10-PCS governs inpatient procedure coding. The MS-DRGs listed below reflect typical assignments when chemodenervation is performed during an inpatient rehabilitation or acute care stay, where the principal diagnosis (stroke, TBI, SCI, MS, CP) drives DRG assignment. The PCS code for chemodenervation itself does not trigger a designated surgical DRG — it is a medical procedure whose DRG impact is felt through the principal diagnosis and CC/MCC capture.
Representative DRGs by Principal Diagnosis Category
| MS-DRG | Title | GMLOS | Key Driver |
|---|---|---|---|
| 056 | Degenerative Nervous System Disorders with MCC | ~5.9 days | MS, Parkinson’s — high-severity comorbidity or complication |
| 057 | Degenerative Nervous System Disorders without MCC | ~3.4 days | MS or Parkinson’s without qualifying secondary diagnoses |
| 061 | Acute Ischemic Stroke with Use of Thrombolytic Agent with MCC | ~5.8 days | Stroke principal dx + tPA administered; spasticity usually emerges post-acutely |
| 065 | Intracranial Hemorrhage or Cerebral Infarction with MCC | ~5.0 days | Acute stroke admission with high-severity comorbidities |
| 066 | Intracranial Hemorrhage or Cerebral Infarction with CC | ~3.6 days | Stroke admission with moderate CC |
CC/MCC Capture in Neurological Admissions
When patients with spasticity are admitted for acute or subacute neurological conditions, the following frequently co-documented diagnoses carry CC/MCC weight and should be coded when clinically supported:
🔧 ICD-10-PCS Equivalents (Inpatient Facility Coding)
| PCS Code | Full Description | Notes |
|---|---|---|
3E0M3GC | Introduction of Other Therapeutic Substance into Muscle, Percutaneous Approach | Primary PCS code for botulinum toxin injection into extremity muscle(s); used regardless of which specific extremity is injected — body part “M” captures Muscle as a system |
PCS Character Analysis — 3E0M3GC
| Position | Character | Value | Definition |
|---|---|---|---|
| 1 | Section | 3 | Administration |
| 2 | Body System | E | Physiological Systems and Anatomical Regions |
| 3 | Root Operation | 0 | Introduction (putting in or on a therapeutic substance) |
| 4 | Body Part | M | Muscle |
| 5 | Approach | 3 | Percutaneous |
| 6 | Substance | G | Other Therapeutic Substance |
| 7 | Qualifier | C | Other Substance |
PCS Coding Note
When chemodenervation is performed bilaterally or in multiple extremities, most facilities assign one PCS code (3E0M3GC) since the body part “Muscle” (M) encompasses the musculature systemically and does not distinguish individual limbs. Facilities may assign multiple PCS lines if their policy requires distinguishing each extremity treated — confirm with your facility compliance team and PCS Official Guidelines Section B4 (Body Part Guidelines) before coding multiple lines for the same body part value.
📝 Coding Examples
Example 1 — Office: Post-Stroke Upper Limb Spasticity, Single Extremity
Clinical Scenario: A 67-year-old male with a history of right-sided ischemic stroke 18 months prior presents with right upper limb flexor spasticity. The physician injects onabotulinumtoxinA (Botox) into 3 muscles: right biceps brachii (50 units), right flexor carpi radialis (25 units), and right flexor digitorum superficialis (25 units). Total dose: 100 units. EMG guidance is used to confirm needle placement. No separately identifiable E/M is documented.
| Field | Code | Rationale |
|---|---|---|
| CPT 1 | 64642-RT | Chemodenervation, right upper extremity; 3 muscles (1-4 muscle range) |
| CPT 2 | 95874 | Needle EMG guidance for chemodenervation; list separately; one code per extremity |
| Drug | J0585 × 100 | OnabotulinumtoxinA, 100 units administered; bill in units matching documented dose |
| PDx | I69.351 | Hemiplegia/hemiparesis following cerebral infarction, right dominant side — most specific sequela code |
Note
Example 2 — Office: Cerebral Palsy, Bilateral Lower Extremity Spasticity, 2 Muscles Each Limb
Clinical Scenario: A 14-year-old with spastic diplegic cerebral palsy presents for bilateral lower extremity botulinum toxin injection. The physician injects abobotulinumtoxinA (Dysport) into 2 muscles of the right lower extremity (medial gastrocnemius 200 units, lateral gastrocnemius 100 units — documented as 2 distinct muscles) and 2 muscles of the left lower extremity (medial gastrocnemius 200 units, lateral gastrocnemius 100 units). Total dose: 600 units. Ultrasound guidance used bilaterally.
| Field | Code | Rationale |
|---|---|---|
| CPT 1 | 64642-RT | Chemodenervation, right lower extremity; 2 muscles |
| CPT 2 | 64643-LT | Chemodenervation, left lower extremity; 2 muscles; add-on code — no modifier -51 needed |
| CPT 3 | 76942 | Ultrasound guidance; report once per session per CPT guidelines (confirm payer policy on units) |
| Drug | J0586 × 120 | AbobotulinumtoxinA 600 units ÷ 5 units per billing unit = 120 billing units |
| PDx | G80.1 | Spastic diplegic cerebral palsy |
Warning
Billing units for J0586 (Dysport) are per 5 units of drug, not per total units administered. 600 units of Dysport ÷ 5 = 120 billing units. This is a common drug billing error that results in either significant underpayment or — if units are inflated — potential fraud exposure. Always convert the administered dose to the correct billing unit count for each J-code’s defined increment.
Example 3 — Office: Quad Limb Spasticity (MS), All Four Extremities, 1-4 Muscles Each, with Separately Identifiable E/M
Clinical Scenario: A 52-year-old female with progressive multiple sclerosis and quad limb spasticity presents for her quarterly chemodenervation session. The physician injects 3 muscles in the right upper extremity, 2 muscles in the left upper extremity, 3 muscles in the right lower extremity, and 3 muscles in the left lower extremity. A separately identifiable E/M service is also documented — the physician evaluated new onset urinary urgency, reviewed MRI findings, and adjusted her disease-modifying therapy.
| Field | Code | Rationale |
|---|---|---|
| CPT 1 | 99214-25 | E/M, established patient, moderate complexity; -25 documents separately identifiable service — note must reflect distinct MDM beyond pre-injection assessment |
| CPT 2 | 64642 | First extremity (right upper), 3 muscles; no laterality modifier required but recommended |
| CPT 3 | 64643 | Second extremity (left upper), 2 muscles; add-on, no -51 |
| CPT 4 | 64643 | Third extremity (right lower), 3 muscles; second unit of add-on |
| CPT 5 | 64643 | Fourth extremity (left lower), 3 muscles; third unit of add-on |
| PDx | G35.- | Multiple sclerosis |
Note
Three units of 64643 are appropriate here — one for each additional extremity beyond the first. The MUE for 64643 is 3 per date of service, matching the anatomical maximum of 3 additional extremities beyond the first. Do not append modifier -51 to the add-on codes — add-on codes are inherently exempt from the multiple procedure reduction.
⚠️ Common Coding Pitfalls
-
Counting injection sites instead of muscles: The code family (64642/64644) is defined by muscles injected, not injection sites. A muscle injected at 3 needle locations = 1 muscle. Inflating the muscle count based on injection sites constitutes upcoding.
-
Reporting 64642 and 64644 for the same extremity: These are mutually exclusive for the same limb. If 5 or more muscles are injected in the first extremity, 64644 is the correct primary code — not 64642 + 64644 together.
-
Failing to bill the J-code separately: The botulinum toxin drug (J0585, J0586, J0587, J0588) is always a separate line item from the procedure code and is typically the majority of the encounter’s reimbursement. Omitting the drug billing is one of the most costly revenue cycle errors in chemodenervation practices.
-
Billing 64643 without 64642 or 64644: 64643 is an add-on code and cannot stand alone. If 64642 or 64644 is missing from the claim, 64643 will be denied as an orphaned add-on.
-
Using modifier -51 on 64643: Add-on codes (64643, 64645, 64647) are exempt from modifier -51 by definition. Appending -51 to an add-on code is incorrect and may cause claim processing errors or reduced payment.
-
Missing documentation of muscle count and identity: The operative or procedure note must explicitly name and count each injected muscle to support both code selection and audit defense. “Botox injected into arm and leg” is not sufficient documentation for 64642 and 64643.
📎 Sources
AMA CPT 2025 Professional Edition · CMS 2025 Medicare Physician Fee Schedule Final Rule (CMS-1807-F) · CMS RVU25A Relative Value Files · CMS Billing and Coding Article A57185 — Botulinum Toxin Injections · CMS Billing and Coding Article A52848 — Botulinum Toxins · NCCI Policy Manual Chapter 11 (Nervous System), CMS 2024-2025 · ICD-10-CM Official Guidelines for Coding and Reporting FY2025 · ICD-10-PCS Official Guidelines for Coding and Reporting FY2025 · AAPC Neurology/PM&R Coding Reference 2025 · RVU Edge CPT 64642 Profile (2026) · Frontiers in Neurology — Botulinum Toxin Utilization, Treatment Patterns, and Healthcare Resource Use (PMC10427537) · Practical Neurology — Botulinum Toxin Billing & Coding Update (2026)